DAVID BLALOCK: Open Payments
NPI 1922076124 · WAUCHULA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$437 in 16 payments from 5 companies in 2025. Trend: 2023 $539 · 2024 $714 · 2025 $437
Food & beverage: $437
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $309 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $43 |
| Lilly USA, LLC | 2 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $30 |
| Abbott Laboratories | 1 | $24 |
Products named: BREZTRI, FARXIGA, AIRSUPRA, JARDIANCE, VPRIV, FREESTYLE LIBRE 3, MOUNJARO, ZEPBOUND.
Industry payments across FL — which companies pay providers there.
